Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • Br

Calculated preset reference · not batch-certified. 18 non-hydrogen atoms shown; hydrogens omitted.

Structure Context: Calculated reference geometry, not a measured batch structure or conformation.

Model data & sources
Depicted Formula
C16H20BrN
Depicted CAS
87913-26-6
Depicted Form
free base
Calculation method
RDKit · ETKDGv3 · MMFF94
Reports
3 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

Bromantane

Nootropics

Published formats

  • Liquid Dropper 30ml/100mg per ml/3g
  • Dry-Fill Capsule 60ct/50mg/3g
  • Powder 5g
  • Aliquot Vial 10ml/100mg per ml/1g
What is the difference between these?
Liquid Dropper
The compound already in solution, in a dropper bottle. The label gives the amount per millilitre, the bottle volume and the total.
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Aliquot Vial
The compound already in solution, in a small sealed vial. Less volume than the dropper bottle and more per millilitre, so read the total rather than the size. Where a carrier is used it is named in brackets.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number87913-26-6
Molecular FormulaC₁₆H₂₀BrN
Molecular Weight306.24
IUPAC DesignationN-(4-bromophenyl)adamantan-2-amine
Physical FormRefer to product documentation
Storage RequirementsRefer to product documentation
Chemical / Salt Formfree base
Solution VehicleMCT Oil
Other NamesBromantan, Ladasten, bromontan, UNII-N1ILS53XWK, N1ILS53XWK, SCHEMBL737152, CHEMBL4303520, DTXSID40405333, AKOS004120981, AKOS037644786, AS-54469
Capsule Concentration50mg x 60ct
Liquid Concentration and Solution100mg/ml (MCT Oil)
Aliquot Concentration and Solution100mg/ml Vial (MCT Oil, Benzyl Benzoate, Benzyl Alcohol)
Bulk Powder Quantity5g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Bromantane

Bromantane (also researched as Ladasten or ADK-709) is a synthetic adamantane derivative. Bromantane is valued in neurochemical research due to its non-receptor-mediated, transcriptional mechanism of action. Rather than forcing the rapid release of existing neurotransmitter pools or blocking reuptake channels, it acts on gene expression pathways to upregulate the cellular machinery responsible for dopamine biosynthesis. This unique profile makes it an essential tool for investigators studying the metabolic and transcriptional regulation of dopaminergic pathways.

Physical & Handling Properties

Property Specification
Solution Base MCT Oil

Research Applications & Mechanism of Interest

The primary academic interest in Bromantane lies in its novel transcriptional influence on catecholamine biosynthesis. Research published in Neuroscience and Behavioral Physiology demonstrates that the compound's effects are mediated through the genomic upregulation of critical dopaminergic enzymes rather than direct receptor interaction.

Primary fields of investigative research include:

  • Upregulation of Biosynthetic Enzymes: Evaluating how the compound stimulates the expression of tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC)—the rate-limiting and terminal enzymes, respectively, in the synthesis of dopamine.

  • Transporter Pharmacology Comparison: Serving as a negative control in transporter assays. Because Bromantane lacks functional affinity for the dopamine transporter (DAT), researchers utilize it to isolate transcriptional synthesis changes from synaptic reuptake inhibition.

  • Transcriptional Kinetics: Mapping the prolonged molecular timescale of gene-expression-mediated monoamine regulation (occurring over hours) compared to the millisecond-range synaptic transmission changes triggered by traditional stimulants.

  • Anti-Doping & Forensic Assays: Due to its classification by the World Anti-Doping Agency (WADA) under class S6.A (Non-Specified Stimulants), Bromantane is highly relevant to sports science. Investigators deploy it as a primary reference standard for developing, validating, and calibrating doping-control detection methodologies.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Further reading: Bromantane research overview

Frequently Asked Research Questions

How does Bromantane's dopamine-related mechanism differ from classical stimulants?

Traditional stimulants (such as amphetamine or methylphenidate) act directly on transport proteins to inhibit reuptake or force immediate neurotransmitter release. Bromantane operates via genomic pathways, upregulating the actual synthesis capacity of dopamine by increasing the expression of the rate-limiting enzymes tyrosine hydroxylase and AADC.

Is Bromantane soluble in aqueous laboratory assays?

No. Bromantane is poorly soluble in water and soluble in organic solvents such as DMSO.

Scientific References

  1. Salimov, R. M., et al. (2001). "The effects of ladasten on the levels of monoamines and their metabolites in the rat brain." Neuroscience and Behavioral Physiology, 31(6), 613–619. doi:10.1023/A:1012351214352.

  2. Grekhova, T. V., et al. (1995). "Effect of bromantane on the dopaminergic system of the rat brain." Bulletin of Experimental Biology and Medicine, 119(3), 262–264. doi:10.1007/BF02445831.

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batch KC-BRM-05.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.